Package insert - PDFSEARCH.IO - Document Search Engine

Package insert
Results: 688

#	Item
471	Important New Prescribing Information March 7, 2003 Dear Healthcare Professional: Biogen wishes to inform you of several changes to the prescribing information for AVONEX� (Interferon beta-1a). Since AVONEX was introdu Add to Reading List Source URL: www.fda.gov Language: English Cytokines Medical terms Patient safety Food and Drug Administration Interferon beta-1a Biogen Idec Package insert Adverse effect MedWatch Medicine Health Pharmacology
472	National Pharmacy (Applicability of the contents of articles in the National Pharmacy Com assumed and can only be ascertained by exami DEA Issues Guidance on Dispensing and Add to Reading List Source URL: www.nabp.net Language: English - Date: 2010-04-06 17:55:44 Health Food and Drug Administration Prescription medication Medical prescription Package insert Adverse effect Pharmaceutical industry Pharmaceutical drug Pharmacy Medicine Pharmacology Pharmaceutical sciences
473	Microsoft Word - Dr. McClellan's speechv3 _for posting to talkaboutr.org_.d… Add to Reading List Source URL: www.talkaboutrx.org Language: English - Date: 2006-06-22 15:10:30 Medical terms Patient safety Pharmaceuticals policy Healthcare Package insert Food and Drug Administration Medical error Prescription medication Alternative medicine Medicine Health Pharmacology
474	Consumer Health Information www.fda.gov/consumer www.fda.gov/consumer/updates/pregnancy052808.html Pregnant Women Add to Reading List Source URL: www.fda.gov Language: English Health Food and Drug Administration Pharmaceutical industry Pharmaceuticals policy United States Public Health Service Breastfeeding Pregnancy Package insert Center for Drug Evaluation and Research Pharmaceutical sciences Medicine Pharmacology
475	October 2005 Important Prescribing Information Dear Healthcare Provider: Biogen Idec is informing you of important new safety information regarding AMEVIVE® (alefacept). This safety information includes a new CONTRAINDI Add to Reading List Source URL: www.fda.gov Language: English Immunosuppressants Biogen Idec Food and Drug Administration Alefacept MedWatch IDEC Package insert Pharmacovigilance Pharmaceutical sciences Pharmacology Medicine
476	National Pharmacy C (Applicability of the contents of articles in the National Pharmacy Complia and can only be ascertained by examining FDA Issues Nationwide Alert on Counterfeit Add to Reading List Source URL: www.nabp.net Language: English - Date: 2010-04-06 17:33:19 Health Clinical pharmacology Food and Drug Administration Pharmacology Therapeutics United States Public Health Service Package insert Dietary supplement Pharmaceutical sciences Pharmaceutical industry Medicine
477	March 6, 2006 Dear Health Care Professional, (OSI) Eyetech Inc. and Pfizer Inc. would like to inform you about important changes in the Macugen® (pegaptanib sodium injection) Prescribing Information concerning reports o Add to Reading List Source URL: www.fda.gov Language: English Pfizer Type 1 hypersensitivity Ketorolac Anaphylaxis Package insert Intravitreal administration Medicine Health Pegaptanib
478	National Pharmacy C (Applicability of the contents of articles in the National Pharmacy Complian and can only be ascertained by examining th FD&C Act Holds Manufacturers Accountable Add to Reading List Source URL: www.nabp.net Language: English - Date: 2010-04-06 17:33:29 Pharmacology Patient safety Clinical pharmacology Pharmaceuticals policy Pharmacy Over-the-counter drug Medical prescription Pharmacist Package insert Medicine Health Pharmaceutical sciences
479	Tuesday, January 24, 2006 Part II Department of Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-01-24 07:38:07 Pharmacology Food and Drug Administration Pharmaceuticals policy Pharmaceutical industry Drugs Package insert Over-the-counter drug Prescription medication New Drug Application Medicine Health Pharmaceutical sciences
480	IMPORTANT DRUG WARNING February 2006 Dear Healthcare Professional: Bayer Pharmaceuticals Corporation (Bayer) would like to inform you that inadvertent intravenous (IV) administration of the contents of Nimotop® (nimodip Add to Reading List Source URL: www.fda.gov Language: English Calcium channel blockers Dihydropyridines Nitrobenzenes Ethers Nimodipine Pharmaceutical drug Route of administration Package insert Chemistry Organic chemistry Pharmacology

UPDATE